While most C3aR-mediated effects after ischemic stroke involve innate CNS cells such as astrocytes, microglia, and neural stem cells, emerging evidence indicates that adaptive immune cells also contribute to post-ischemic pathology. This evidence concerns the gene C3AR1 and ischemic stroke.